• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

North Carolina Personal Injury & Workers Compensation Attorneys

  • facebook
  • twitter
  • instagram
  • linkedin

Call Us 919-240-4054

Main navigation

  • Camp Lejeune
  • Workers’ Comp
    • Durham, NC
      • Burns and Explosions
      • Durham back injury lawyers
      • Brain Injury
      • Chemical Exposure
      • Construction Accidents
      • Healthcare Workers and COVID-19
      • Occupational Disease
      • Union Members
      • Workplace Violence
  • Personal Injury
    • Durham, NC
      • Burn Injury
      • College Campus Injuries
      • Car Accidents
      • Catastrophic Injuries
      • Premises Liability
      • Product Liability
      • Trucking Accidents
      • Traumatic Brain Injury
    • Charlotte, NC
      • Trucking Accidents
      • Brain Injury Lawyer
      • Burn Injury Lawyer
      • Premises Liability Lawyer
      • Product Liability Lawyer
      • Car Accident Lawyer
      • Catastrophic Injury Lawyer
  • Wrongful Death
    • Durham, NC
    • Charlotte, NC
  • Bicycle Crash
    • Charlotte, NC
  • Our Lawyers
    • Ann E. Groninger
    • Valerie Johnson
    • Helen S. Baddour
    • Drew Culler
    • Jennifer Segnere
    • Speaking Engagements
  • Resources
    • Law Blog
    • Our Community
  • Contact Us
  • Español

November 1, 2013 By nicole

Leukemia drug puts patients at risk of stroke

The Food and Drug Administration (FDA) has suspended sales of a once-promising leukemia drug because of “the risk of life-threatening blood clots and severe narrowing of blood vessels.”

The drug Iclusig, also known as ponatinib, has been linked to severe and sometimes fatal heart attacks, strokes and loss of blood flow to the extremities, sometimes serious enough to cause amputation. Some problems occurred as soon as two weeks after people began taking the drug, the FDA said. Many of the problems occurred in patients with no history of heart disease and in some patients as young as 20 years old.

Initial studies of Iclusig revealed that the drug carried the risk of blood clots in 12 percent of patients. Over time, however, problems with the drug turned out to be far more serious than the earlier studies indicated. The FDA now reports that 24 percent of patients studied for 1.3 years and 48 percent of patients studied for about 2.7 years suffered “serious adverse vascular events” such as strokes and aneurisms.

A spokesperson for the FDA said that the drug, used to treat chronic myeloid leukemia, is not being permanently shelved. The FDA will work with the drug maker to determine which patients will still benefit from the drug. Individuals suffering from leukemia who are currently taking Iclusig are allowed to continue taking the drug, the FDA said.

Approximately 5000 new cases of chronic myeloid leukemia are diagnosed each year, according to the FDA. Ten percent of those patients succumb to the disease.

Filed Under: In the News, Defective Product Tagged With: Health Care

Primary Sidebar

Primary Sidebar

Occupation

  • Bus Drivers
  • Construction Workers
  • First Responders
  • Police Officers
  • Truck Drivers
  • State Employees
  • Union Members

Injury

  • Asbestos Exposure
  • Durham back injury lawyers
  • Brain Injury
  • Burns and explosions
  • Chemical Exposure
  • COVID-19 and Healthcare Workers
  • Occupational Diseases
  • Workplace Violence

Free Legal Resources

  • Workers’ Compensation 101
  • 8 Questions to Answer Before You Are Ever in a Wreck
  • Essentials for Workers’ Comp Success
  • Help for Families of North Carolina Burn Victims

Locations

Durham Office

300 Blackwell St S#101, Durham, NC 27701

Phone: (919) 240-4054

Fax: (888) 412-0421

Charlotte Office

1018 East Blvd., Ste 6 Charlotte, NC 28203

Phone: (704) 200-2009

Fax : (888) 412-0421

Read Our Google Reviews

Get more stuff

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.

We respect your privacy and take protecting it seriously.

Copyright Johnson & Groninger PLLC Law Firm SEO by EverSpark Interactive